Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

1(20%)

Phase Distribution

Ph not_applicable

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

N/ANon-phased studies

5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Other(1)

Detailed Status

Completed3

Terminated1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

terminated120%

completed360%

unknown120%

Recent Activity

0 active trials

Showing 5 of 5

completednot_applicable

NCP 2.0 Repeat Study

NCT04661592

completednot_applicable

Assessing Repeatability of NeuroCatch Platform™ Measurements: An Initial Assessment

NCT03421405

terminatednot_applicable

Assessing Brain Changes Throughout the ABI Wellness Program

NCT03438851

completednot_applicable

Development of a Reference Interval Database With the NeuroCatch™ Platform

NCT03835962

unknownnot_applicable

Neurophysiological Measurements Using the NeuroCatch™ Platform in Pediatric Concussion

NCT03889483

Clinical Trials (5)

Showing 5 of 5 trials

NCT04661592Not Applicable

NCP 2.0 Repeat Study

Completed

NCT03421405Not Applicable

Assessing Repeatability of NeuroCatch Platform™ Measurements: An Initial Assessment

Completed

NCT03438851Not Applicable

Assessing Brain Changes Throughout the ABI Wellness Program

Terminated

NCT03835962Not Applicable

Development of a Reference Interval Database With the NeuroCatch™ Platform

Completed

NCT03889483Not Applicable

Neurophysiological Measurements Using the NeuroCatch™ Platform in Pediatric Concussion

Unknown

All 5 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 5